Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-24-105905
Filing Date
2024-09-12
Accepted
2024-09-12 16:05:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4494
  Complete submission text file 0000950170-24-105905.txt   6059
Mailing Address C/O ALBIREO PHARMA INC. 50 MILK ST. 16TH FLOOR BOSTON MA 02109
Business Address
Sermon Charles (Reporting) CIK: 0001687318 (see all company filings)

Type: 144

Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Subject) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38452 | Film No.: 241294948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)